New Rhein logo

New Rhein

North America, Pennsylvania, United States, Philadelphia

Description

New Rhein is a global venture capital firm investing in healthcare.

Investor Profile

New Rhein has made 9 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Seed (11%)
  • Series C (11%)
  • Series D (11%)

Country Focus

  • United States (56%)
  • Israel (22%)
  • Switzerland (11%)
  • Belgium (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Commercial
  • Manufacturing
  • Medical Device
  • Dietary Supplements
  • Men's
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does New Rhein frequently co-invest with?

JC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Takoa Invest
North America, Minnesota, United States, Finland
Co-Investments: 1
Central Texas Angel Network
North America, Texas, United States, Austin
Co-Investments: 1
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 1
LionBird
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
MC
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
PC
North America, Massachusetts, United States, Natick
Co-Investments: 1
Corundum Open Innovations
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Lightspeed Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Primavera Capital Group
Asia, Beijing, China, Beijing
Co-Investments: 1

Which angels does New Rhein often collaborate with?

Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by New Rhein?

Corsair Pharma

Sunnyvale, California, United States

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

Dietary SupplementsManufacturingTherapeutics
Series BSep 20, 2023
Amount Raised: $23,000,000
Theranica

Netanya, HaMerkaz, Israel

Theranica is an Israeli biomedical technology company focused on developing electronic and wireless communication technology.

BiotechnologyMedicalTherapeutics
Series CAug 29, 2022
Amount Raised: $45,000,000
Butterfly Medical

Yoqne`am `illit, HaZafon, Israel

Butterfly Medical has developed a fast, non-invasive alternative treatment to first-line benign prostate hyperplasia medication & surgery.

Health CareMedicalMen's
Series BOct 6, 2020
Amount Raised: $7,000,000
American Injectables

Tampa, Florida, United States

American Injectables is a sterile injectable manufacturer of parenteral drugs.

ManufacturingMedicalPharmaceutical
Series ASep 24, 2020
Amount Raised: $10,000,000
Neuraptive Therapeutics

Lafayette, Colorado, United States

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.

BiotechnologyCommercialHealth CareTherapeutics
Series ADec 19, 2018
Amount Raised: $11,500,000
Neuraptive Therapeutics

Lafayette, Colorado, United States

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.

BiotechnologyCommercialHealth CareTherapeutics
SeedSep 6, 2017
Amount Raised: $1,000,000
Softhale

Diepenbeek, Limburg, Belgium

Softhale is developing an innovative handheld non-thermal and mechanical nebulizer for effective respiratory drug delivery.

BiotechnologyHealth CareMedicalMedical Device
Series ANov 30, 2016
Chase Pharmaceuticals

Washington, District of Columbia, United States

Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.

BiotechnologyHealth CareMedical
Series BMay 12, 2014
Amount Raised: $21,000,000
Biocartis

Lausanne, Vaud, Switzerland

Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.

BiotechnologyHealth DiagnosticsMedical Device
Series DDec 12, 2012
Amount Raised: $45,032,933